Inflazyme Pharmaceuticals Ltd. Advises on the Proposed Merger of Biolipox, the Proposed Purchaser of Inflazyme’s Assets, and Orexo AB

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 17, 2007) - Inflazyme Pharmaceuticals Ltd., (TSX:IZP) today announced that it has been provided with a press release concerning the proposed merger of Biolipox AB (“Biolipox”) and Orexo AB, (OMX Nordic List, Mid Cap: ORX) (“Orexo”).